Source: Eur Respir J, 57 (2) 2002127; 10.1183/13993003.02127-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Olaf Holz, Benjamin Waschki, Henrik Watz, Anne Kirsten, Mustafa Abdo, Frauke Pedersen, Markus Weckmann, Oliver Fuchs, Anna-Maria Dittrich, Gesine Hansen, Matthias V. Kopp, Erika von Mutius, Klaus F. Rabe, Jens M. Hohlfeld, Thomas Bahmer. Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort. Eur Respir J, 57 (2) 2002127; 10.1183/13993003.02127-2020

Member's Comments

No comment yet.

Related content which might interest you: Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Volatile organic compounds in COPD: Is hexanal an inflammation biomarker? Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 Volatile organic compounds (VOCs) in COPD patients with exacerbation Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study Source: Eur Respir J 2013; 42: 98-106 Year: 2013 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Exhaled volatile organic compounds differentiate between children with atopic asthma and healthy controls Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009 Can exhaled volatile organic compounds predict asthma exacerbations in children? Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Limited clinical value of exhaled volatile organic compound measurements in childhood asthma Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018 Year: 2018 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Exhaled endogenous particles in a general population sample enriched with asthma subjects Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Exhaled volatile organic compounds as markers for medication use in asthma Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019 Year: 2020 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010